Cencora adds Sanchez to board as value hits $61.6 billion
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Cencora Inc. appointed Robert E. Sanchez as an independent director effective October 1, 2026, expanding the pharmaceutical distributor's board to eleven members. The stock carried a market value of $61.6 billion as of October 6, 2026, after third-quarter revenue of $84.75 billion, up 5.10 percent year-over-year. The company also raised its fiscal 2026 adjusted earnings-per-share guidance, citing continued growth in specialty distribution and logistics.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.